AIMC Topic: Drug Discovery

Clear Filters Showing 141 to 150 of 1501 articles

Attention-based deep learning for accurate cell image analysis.

Scientific reports
High-content analysis (HCA) holds enormous potential for drug discovery and research, but widely used methods can be cumbersome and yield inaccurate results. Noisy and redundant signals in cell images impede accurate deep learning-based image analysi...

Semisupervised Contrastive Learning for Bioactivity Prediction Using Cell Painting Image Data.

Journal of chemical information and modeling
Morphological profiling has recently demonstrated remarkable potential for identifying the biological activities of small molecules. Alongside the fully supervised and self-supervised machine learning methods recently proposed for bioactivity predict...

Data and AI-driven synthetic binding protein discovery.

Trends in pharmacological sciences
Synthetic binding proteins (SBPs) are a class of protein binders that are artificially created and do not exist naturally. Their broad applications in tackling challenges of research, diagnostics, and therapeutics have garnered significant interest. ...

Unveiling key drivers of hepatocellular carcinoma: a synergistic approach with network pharmacology, machine learning-driven ligand discovery and dynamic simulations.

SAR and QSAR in environmental research
Hepatocellular carcinoma (HCC) ranks fourth in cancer-related mortality worldwide. This study aims to uncover the genes and pathways involved in HCC through network pharmacology (NP) and to discover potential drugs via machine learning (ML)-based lig...

MIFS: An adaptive multipath information fused self-supervised framework for drug discovery.

Neural networks : the official journal of the International Neural Network Society
The production of expressive molecular representations with scarce labeled data is challenging for AI-driven drug discovery. Mainstream studies often follow a pipeline that pre-trains a specific molecular encoder and then fine-tunes it. However, the ...

Drug repositioning for Parkinson's disease: An emphasis on artificial intelligence approaches.

Ageing research reviews
Parkinson's disease (PD) is one of the most incapacitating neurodegenerative diseases (NDDs). PD is the second most common NDD worldwide which affects approximately 1-2 percent of people over 65 years. It is an attractive pursuit for artificial intel...

Drug molecular representations for drug response predictions: a comprehensive investigation via machine learning methods.

Scientific reports
The integration of drug molecular representations into predictive models for Drug Response Prediction (DRP) is a standard procedure in pharmaceutical research and development. However, the comparative effectiveness of combining these representations ...

Deep learning-based discovery of compounds for blood pressure lowering effects.

Scientific reports
The hypotensive side effects caused by drugs during their use have been a vexing issue. Recent studies have found that deep learning can effectively predict the biological activity of compounds by mining patterns and rules in the data, providing a po...

Drug discovery and mechanism prediction with explainable graph neural networks.

Scientific reports
Apprehension of drug action mechanism is paramount for drug response prediction and precision medicine. The unprecedented development of machine learning and deep learning algorithms has expedited the drug response prediction research. However, exist...

CPI-GGS: A deep learning model for predicting compound-protein interaction based on graphs and sequences.

Computational biology and chemistry
BACKGROUND: Compound-protein interaction (CPI) is essential to drug discovery and design, where traditional methods are often costly and have low success rates. Recently, the integration of machine learning and deep learning in CPI research has shown...